Melissa Burgess, MD
UPMC Cancer Pavilion
Medical oncology; clinical and translational research; sarcoma; immunotherapy
My research is focused on clinical and translational studies of soft tissue and bone sarcomas. Currently, I am investigating an immunotherapy utilizing an anti-PD1 inhibitor for patients with advanced sarcomas. In the future, I plan to further study novel immunotherapeutic approaches for advanced sarcomas, particularly with combinatorial strategies.
- Burgess M, Gorantla V, Weiss K, Tawbi H. Immunotherapy in sarcoma: Future horizons. Curr Oncol Rep. 2015 Nov;17(11):52. PubMed Link
- Burgess M, Tawbi H. Immunotherapeutic approaches to sarcoma. Curr Treat Options Oncol. 2015 Jun;16(6):26. PubMed Link
- Burgess M and Puhalla S. BRCA 1/2-mutation related and sporadic breast and ovarian cancers: More alike than different. Front Oncol. 2014 Feb 27;4:19. PubMed Link
- Moidel MA, Belz EE, Czambel RK, Rubin RT, Rhodes ME. Novel in vitro perfusion system for the determination of hypothalamic-pituitary-adrenal axis responses. J Pharmacol Toxicol Methods. 2006 May-Jun;53(3):264-71. PubMed Link